PL379527A1 - Zastosowanie insuliny w leczeniu bakteryjnych chorób skóry u człowieka - Google Patents

Zastosowanie insuliny w leczeniu bakteryjnych chorób skóry u człowieka

Info

Publication number
PL379527A1
PL379527A1 PL379527A PL37952706A PL379527A1 PL 379527 A1 PL379527 A1 PL 379527A1 PL 379527 A PL379527 A PL 379527A PL 37952706 A PL37952706 A PL 37952706A PL 379527 A1 PL379527 A1 PL 379527A1
Authority
PL
Poland
Prior art keywords
insulin
human
treatment
application
skin diseases
Prior art date
Application number
PL379527A
Other languages
English (en)
Inventor
Wojciech Krzysztof Bielicki
Original Assignee
Wojciech Krzysztof Bielicki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wojciech Krzysztof Bielicki filed Critical Wojciech Krzysztof Bielicki
Priority to PL379527A priority Critical patent/PL379527A1/pl
Publication of PL379527A1 publication Critical patent/PL379527A1/pl

Links

PL379527A 2006-04-25 2006-04-25 Zastosowanie insuliny w leczeniu bakteryjnych chorób skóry u człowieka PL379527A1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL379527A PL379527A1 (pl) 2006-04-25 2006-04-25 Zastosowanie insuliny w leczeniu bakteryjnych chorób skóry u człowieka

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL379527A PL379527A1 (pl) 2006-04-25 2006-04-25 Zastosowanie insuliny w leczeniu bakteryjnych chorób skóry u człowieka

Publications (1)

Publication Number Publication Date
PL379527A1 true PL379527A1 (pl) 2007-10-29

Family

ID=43016795

Family Applications (1)

Application Number Title Priority Date Filing Date
PL379527A PL379527A1 (pl) 2006-04-25 2006-04-25 Zastosowanie insuliny w leczeniu bakteryjnych chorób skóry u człowieka

Country Status (1)

Country Link
PL (1) PL379527A1 (pl)

Similar Documents

Publication Publication Date Title
ZA200801511B (en) Novel diazaspiroalkanes and their use for treatment of CCR8 medicated diseases
IL236831A0 (en) Expression of micro rna in peripheral narrow blood vessels in the human body, and their uses
SI2104682T1 (sl) Diagnostika in zdravljenje Alzheimerjeve bolezni in drugih nevrodementnih bolezni
SG10201609507TA (en) Use of microvesicles in diagnosis, prognosis and treatment of medical diseases and conditions
IL190733A0 (en) Methods and compositions for use in treatment of patients with autoantibody positive diseases
GB0610867D0 (en) Treatment of pain
IL193748A0 (en) Treatment of pain
PT2614832T (pt) Diagnóstico de pré-eclâmpsia
IL179616A0 (en) Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones
EP2206714A4 (en) AGENT FOR THE PREVENTION AND / OR TREATMENT OF SKIN DISEASES
IL191908A0 (en) Use of alkanedicarboxylic acids and retinoids for treatment of rosacea and other inflammatory skin diseases
PL1981515T3 (pl) Leczenie urazów i chorób mózgu za pomocą MAPC
EP2148667A4 (en) USE OF CYCLOHEXANHEXOL DERIVATIVES IN THE TREATMENT OF EYE DISEASES
EP2099465A4 (en) IMPROVEMENT BY REISHI OF HUMAN TISSUE PROGENITOR CELLULAR ADHESION AND DIFFERENTIATION
EP2063902A4 (en) THERAPEUTIC CELL MEDICAMENT WITH STEM CELLS OF SKIN
IL213703A (en) Compounds for the treatment of pain and other diseases
GB0608647D0 (en) Methods of diagnosis and treatment
PL1998747T3 (pl) Zastosowanie fermentowanego produktu mlecznego do pielęgnacji skóry
EP1773882A4 (en) DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH SIGLEC-6
PL1818064T3 (pl) Sposoby traktowania skóry w celu wzmocnienia jej leczenia terapeutycznego
EP1922063A4 (en) METHOD FOR TREATING PAIN IN PATIENTS
EP1774975A4 (en) USE OF A HUMAN LYSOZYM PREPARATION FOR THE TREATMENT OF ACNE
PL379527A1 (pl) Zastosowanie insuliny w leczeniu bakteryjnych chorób skóry u człowieka
GB0610868D0 (en) Treatment of pain
EP1846013A4 (en) TREATMENT OF SKIN DISEASES

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)